CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,804,416 | -9.7% | 502,526 | -0.0% | 0.48% | -2.7% |
| Q2 2023 | $16,392,000 | -4.2% | 502,527 | +3.3% | 0.49% | -11.9% |
| Q1 2023 | $17,112,000 | -21.5% | 486,272 | +2.3% | 0.55% | -30.1% |
| Q4 2022 | $21,786,173 | -48.3% | 475,473 | -45.3% | 0.79% | -50.8% |
| Q3 2022 | $42,149,000 | +25.9% | 869,952 | +2.1% | 1.61% | +21.1% |
| Q2 2022 | $33,471,000 | +12.9% | 851,905 | +5.8% | 1.33% | +35.0% |
| Q1 2022 | $29,653,000 | +5.0% | 805,574 | +30.0% | 0.98% | +16.4% |
| Q4 2021 | $28,244,000 | +26.7% | 619,664 | -0.6% | 0.85% | +22.8% |
| Q3 2021 | $22,289,000 | – | 623,656 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |